Remove Bioethics Remove FDA Remove Public Health
article thumbnail

Public Health Product Hops

Bill of Health

Dmitry’s talk, “Evergreening: The FDA’s Role in the Creation of Balanced Rights for Pharmaceutical Improvements,” was developed into an article and published in the Iowa Law Review in 2019 titled “The More Things Change: Improvement Patents, Drug Modifications, and the FDA.”

article thumbnail

Petrie-Flom Welcomes 2024-2025 Student Fellows

Bill of Health

2025) is Assistant Professor at Brown University’s Department of Psychiatry and Human Behavior and a master’s candidate at Harvard Medical School’s Center for Bioethics. MPH 2025) is a third-year dual degree law and public health student. Zain Khalid (M.B.E Jessica Samuels (J.D./MPH

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Considerations for Patient-Reported Outcome Measures

Bill of Health

PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. Health Pol’y, Law, and Ethics 1 (2023). The post Key Considerations for Patient-Reported Outcome Measures first appeared on Bill of Health.

article thumbnail

Litigation Challenges Prioritization of Race or Ethnicity in Allocating COVID-19 Therapies

Bill of Health

Food & Drug Administration (FDA) encouraged several states to adopt policies that prioritized race or ethnicity in the allocation of monoclonal antibody treatments and oral antivirals for the treatment of SARS-CoV-2. By James Lytle. Recent guidance from the U.S. less likely to receive the treatment than whites.

COVID-19 246
article thumbnail

IoT and The Rise of the Machines in Healthcare

Health Populi

. “During the chaos and confusion, threat actors launched cyberattacks,” Ordr observed in the wake of the public health crisis. In this Rise of the Medical Machines, the major risks for health care organizations were that, 68% of health care deployments had more than 10 FDA recalls.

COVID-19 174
article thumbnail

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 3 of 5 – Apple as “Intelligent Health Guardian”

Jane Sarashon

The second graphic from the report breaks out the health consumer/health citizen from the health/care industry and ecosystem: Being that intelligent guardian for our health and fitness, including partnering with third parties for digital health tools and apps, and. It will be about health.”

article thumbnail

Book Review: ‘The Truth Pill: The Myth of Drug Regulation in India’

Bill of Health

By Aparajita Lath. The Truth Pill , authored by Dinesh Thakur and Prashant Reddy , is a monumental work that convincingly shows that drug regulation is but a myth in India. In their investigative style, the authors explain drug regulation in India through the lens of history, both Indian and global.